Understanding Human Behavior To Help Improve Patient Adherence

BEAMER is delighted to announce that its project lead Claire Everitt, the Device Design and [...]

Read More
BEAMER Gains Positive Reception within the Dutch CRO Community

Recently, Sjaak Bloem and I had the privilege of presenting the BEAMER project to the [...]

Read More
BEAMER Meeting in Thessaloniki Sets Vision for Future Healthcare Solutions

It has become a tradition within BEAMER to gather during the autumn months for a [...]

Read More
BEAMER’s Innovative Research on AI-Driven Treatment Adherence Prediction Recognised at International Conference

In a remarkable showcase of cutting-edge research and innovation, Beatriz Merino from BEAMER’s Work Package [...]

Read More
BEAMER awarded as the best research project at the semFYC Conference 2023

The 43rd edition of the Spanish Society of Family and Community Medicine (semFYC) Conference was [...]

Read More
BEAMER Project Members Make Further Advances in Copenhagen, Denmark

This past month, partners from the BEAMER project gathered in the coastal city of Copenhagen, [...]

Read More
Where Dialogue Meets Actions: The BEAMER Consortium Gathering in Portugal

Not much time has passed since the entire BEAMER consortium came together in Porto (Portugal) [...]

Read More

Supported by a grant from IMI, the project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 101034369. This joint undertaking receives support from the European Union’s Horizon 2020 research and innovation programme, the European Federation of Pharmaceutical Industries and Associations [EFPIA] and Link2Trials. The total budget is 11.9 M€ for a project duration of 60 months.

Information on this website reflects project owner’s views and neither IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained therein.

Who’s Behind BEAMER
Subscribe to Newsletter
Press Office

Privacy Policy and Cookies

Follow us: